Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
27.50
-0.50 (-1.79%)
Jun 20, 2025, 4:45 PM CET
-57.95%
Market Cap 497.43M
Revenue (ttm) 359.79M
Net Income (ttm) -4.95M
Shares Out 18.36M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE 19.67
Dividend n/a
Ex-Dividend Date n/a
Volume 27,222
Average Volume 48,152
Open 28.10
Previous Close 28.00
Day's Range 27.50 - 28.50
52-Week Range 26.80 - 69.90
Beta 0.01
RSI 31.73
Earnings Date May 22, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.